Tag: influenza vaccine quadrivalent
Vaxxas’ needle-free seasonal influenza vaccine enters clinical trial
Vaxxas has commenced the Phase I clinical trial of the first needle-free inactivated seasonal influenza vaccine quadrivalent (IIV4) candidate via its proprietary high-density microarray patch (HD-MAP) technology.
Featured Article
Expressions of interest sought for Wax Converters Textiles
Salea Advisory, on behalf of Administrator Sule Arnautovic, is inviting expressions of interest for the sale or assignment of Wax Converters Textiles Pty Limited, a well-established manufacturing business located in Rutherford, NSW.
